Gynest

Gynest is a vaginal medication that contains the estrogen estriol. It is marketed in the European Union and is supplied without a specified strength. The product is intended for local administration to the vaginal mucosa, delivering estrogenic activity directly to target tissues. It belongs to the estrogen drug class and is used under medical supervision for conditions related to low estrogen levels in the vaginal area.

Gynest is prescribed for several gynecological situations where local estrogen supplementation is desired, particularly when systemic hormone therapy is not indicated or when targeted treatment of the vaginal epithelium is preferred.

- Relief of vaginal dryness associated with menopause. - Management of mild atrophic vaginitis symptoms. - Adjunct therapy after radiation therapy affecting the pelvic region. - Support of vaginal tissue health in hypoestrogenic states. - Preparation of the vaginal mucosa prior to diagnostic procedures. - Treatment of mild urinary symptoms linked to vaginal atrophy.

The vaginal administration of estriol may cause a range of local and systemic effects, most of which are mild and reversible.

Common: - Temporary vaginal irritation or burning sensation. - Light spotting or brownish discharge. - Mild itching or dryness. - Slight increase in vaginal discharge volume. - Mild breast tenderness. - Local swelling of the vulvar area.

Serious: - Unexplained vaginal bleeding. - Signs of estrogen excess such as nausea, headache, or fluid retention. - Allergic reaction with rash, swelling, or difficulty breathing. - Development of endometrial hyperplasia (rare). - Blood clots in deep veins (rare).

Before using Gynest, certain health considerations should be reviewed to ensure safe and effective treatment.

- History of estrogen-sensitive cancers such as breast or endometrial cancer. - Active or past thromboembolic disorders, including deep vein thrombosis or pulmonary embolism. - Unexplained vaginal bleeding or abnormal uterine bleeding. - Liver disease that may affect hormone metabolism. - Pregnancy or breastfeeding status, as estriol exposure may affect the fetus or infant. - Use in patients with known hypersensitivity to estriol or any excipients.

Estriol can interact with other medications or substances that influence estrogen pathways or clotting mechanisms.

Avoid: - Combined use with systemic estrogen therapy or high-dose hormonal contraceptives. - Concurrent anticoagulant therapy such as warfarin without monitoring. - Use with selective estrogen receptor modulators (SERMs) like tamoxifen.

Use with caution: - Medications that inhibit CYP3A4 enzymes (e.g., ketoconazole, erythromycin) may alter estriol metabolism. - Hormonal treatments that affect liver function. - Herbal supplements containing phytoestrogens (e.g., soy isoflavones).